Life Science REIT plc is a newly incorporated, externally managed, investment company that intends to carry on business as a REIT and, upon admission, will be an "investing company" for the purposes of the AIM Rules. The Company's investment objective is to provide shareholders with an attractive level of total return. The focus will be capital growth whilst also providing a growing level of income by investing primarily in a diversified portfolio of UK properties that are leased or intended to be leased to tenants operating in the life science sector. The investment strategy targets life science clusters that are focused primarily in the "Golden Triangle" of Oxford, Cambridge and London and also selective opportunities in other emerging clusters around the UK.
Non-Executive Chairman: |
Claire Boyle (née Barnes) |
Senior Independent Director: |
Richard Howell |
Independent Non-Executive Director: |
Michael Taylor, Sally Ann Forsyth |
Address: |
65 Gresham Street, London, United Kingdom |
Phone: |
+44 (0) 207 945 9566 |
Fax: |
|
Website: |
http://www.lifesciencereit.co.uk/ |
Email: |
|